Moderna (MRNA) has had the best year between 2025 and 2026 by a large-cap US stock this year, returning 643.3%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Moderna (MRNA) | 2026 | 643.28% |
Sandisk (SNDK) | 2025 | 577.07% |
Twist Bioscience (TWST) | 2026 | 381.5% |
Sandisk (SNDK) | 2026 | 371% |
Lumentum (LITE) | 2025 | 337.96% |
ViaSat (VSAT) | 2025 | 291.59% |
Bloom Energy (BE) | 2025 | 286.01% |
Western Digital (WDC) | 2025 | 282.2% |
AngloGold Ashanti (AU) | 2025 | 277.7% |
IREN (IREN) | 2025 | 266.34% |
Ast Spacemobile (ASTS) | 2025 | 243.57% |
Micron Technology (MU) | 2025 | 236.96% |
Dell Technologies (DELL) | 2026 | 233.94% |
Guardant Health (GH) | 2025 | 226.85% |
Gold Fields Ltd ADR (GFI) | 2025 | 225.86% |
Seagate Technology (STX) | 2025 | 221.91% |
Celestica (CLS) | 2025 | 218.44% |
Frontline (FRO) | 2026 | 208.29% |
Coeur Mining (CDE) | 2025 | 204.27% |
Kinross Gold (KGC) | 2025 | 202.52% |
Micron Technology (MU) | 2026 | 200% |
Nebius (NBIS) | 2025 | 197.56% |
Robinhood Markets (HOOD) | 2025 | 193.46% |
Marathon Petroleum (MPC) | 2026 | 176.26% |
BridgeBio Pharma (BBIO) | 2025 | 175.24% |
Large-cap stocks are treated as having a market cap of $10B+.